Cargando…

GDC-0575, a CHK1 Inhibitor, Impairs the Development of Colitis and Colitis-Associated Cancer by Inhibiting CCR2(+) Macrophage Infiltration in Mice

BACKGROUND: Checkpoint kinase 1 (CHK1) plays an important role in DNA damage response and cell cycle progression. Thus, targeting CHK1 is an efficient strategy for cancer therapy. PURPOSE: The present study aimed to investigate the potential therapeutic effects of GDC-0575, a CHK1-specific inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Min, Huang, Tianqing, Li, Xiaolan, Shi, Zhiwei, Sheng, Yue, Hu, Mimi, Song, Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058335/
https://www.ncbi.nlm.nih.gov/pubmed/33897258
http://dx.doi.org/10.2147/OTT.S297132
_version_ 1783680991749996544
author Li, Min
Huang, Tianqing
Li, Xiaolan
Shi, Zhiwei
Sheng, Yue
Hu, Mimi
Song, Kui
author_facet Li, Min
Huang, Tianqing
Li, Xiaolan
Shi, Zhiwei
Sheng, Yue
Hu, Mimi
Song, Kui
author_sort Li, Min
collection PubMed
description BACKGROUND: Checkpoint kinase 1 (CHK1) plays an important role in DNA damage response and cell cycle progression. Thus, targeting CHK1 is an efficient strategy for cancer therapy. PURPOSE: The present study aimed to investigate the potential therapeutic effects of GDC-0575, a CHK1-specific inhibitor, in colitis-associated cancer (CAC) and colitis. METHODS: We established a DSS-induced acute colitis model and an azoxymethane/dextran sodium sulfate (DSS)-induced CAC model using mice and tested the effect of GDC-0575 on them. Flow cytometry and immunofluorescence were employed to investigate the infiltration of immune cells, and inflammatory cytokine expression in the colon of mice with CAC or colitis was investigated using ELISA and qPCR. We also investigated the correlation between CHK1 and CCL2/CCR2 in human colorectal cancer (CRC) tissues. RESULTS: Administration of GDC-0575 significantly inhibited CHK1 expression in the colon and dramatically impaired the development of CAC and colitis in mice. Moreover, the inhibition of CHK1 expression resulted in efficient inhibition of infiltration by iNOS-positive macrophages, but had no significant effect on CD4 T cells, CD8 T cells, and myeloid-derived suppressor cells (MDSCs). Significant downregulation of TNF-α, IL-6, and IL-1β and dramatic upregulation of IL-10 were observed in the colons of both mice with CAC and colitis treated with GDC-0575. CCL2 expression was also downregulated by GDC-0575 in both mice with CAC and colitis; this was followed by the inhibition of CCR2(+) macrophage infiltration in the colon. Furthermore, we report a positive correlation between CHK1 expression and CCL2/CCR2 expression in the malignant tissues of patients with CRC. CONCLUSION: Taken together, we infer that GDC-0575 impairs the development of CAC and colitis by regulating cytokine expression and inhibiting CCR2(+) macrophage infiltration in mice colon.
format Online
Article
Text
id pubmed-8058335
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-80583352021-04-22 GDC-0575, a CHK1 Inhibitor, Impairs the Development of Colitis and Colitis-Associated Cancer by Inhibiting CCR2(+) Macrophage Infiltration in Mice Li, Min Huang, Tianqing Li, Xiaolan Shi, Zhiwei Sheng, Yue Hu, Mimi Song, Kui Onco Targets Ther Original Research BACKGROUND: Checkpoint kinase 1 (CHK1) plays an important role in DNA damage response and cell cycle progression. Thus, targeting CHK1 is an efficient strategy for cancer therapy. PURPOSE: The present study aimed to investigate the potential therapeutic effects of GDC-0575, a CHK1-specific inhibitor, in colitis-associated cancer (CAC) and colitis. METHODS: We established a DSS-induced acute colitis model and an azoxymethane/dextran sodium sulfate (DSS)-induced CAC model using mice and tested the effect of GDC-0575 on them. Flow cytometry and immunofluorescence were employed to investigate the infiltration of immune cells, and inflammatory cytokine expression in the colon of mice with CAC or colitis was investigated using ELISA and qPCR. We also investigated the correlation between CHK1 and CCL2/CCR2 in human colorectal cancer (CRC) tissues. RESULTS: Administration of GDC-0575 significantly inhibited CHK1 expression in the colon and dramatically impaired the development of CAC and colitis in mice. Moreover, the inhibition of CHK1 expression resulted in efficient inhibition of infiltration by iNOS-positive macrophages, but had no significant effect on CD4 T cells, CD8 T cells, and myeloid-derived suppressor cells (MDSCs). Significant downregulation of TNF-α, IL-6, and IL-1β and dramatic upregulation of IL-10 were observed in the colons of both mice with CAC and colitis treated with GDC-0575. CCL2 expression was also downregulated by GDC-0575 in both mice with CAC and colitis; this was followed by the inhibition of CCR2(+) macrophage infiltration in the colon. Furthermore, we report a positive correlation between CHK1 expression and CCL2/CCR2 expression in the malignant tissues of patients with CRC. CONCLUSION: Taken together, we infer that GDC-0575 impairs the development of CAC and colitis by regulating cytokine expression and inhibiting CCR2(+) macrophage infiltration in mice colon. Dove 2021-04-15 /pmc/articles/PMC8058335/ /pubmed/33897258 http://dx.doi.org/10.2147/OTT.S297132 Text en © 2021 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Min
Huang, Tianqing
Li, Xiaolan
Shi, Zhiwei
Sheng, Yue
Hu, Mimi
Song, Kui
GDC-0575, a CHK1 Inhibitor, Impairs the Development of Colitis and Colitis-Associated Cancer by Inhibiting CCR2(+) Macrophage Infiltration in Mice
title GDC-0575, a CHK1 Inhibitor, Impairs the Development of Colitis and Colitis-Associated Cancer by Inhibiting CCR2(+) Macrophage Infiltration in Mice
title_full GDC-0575, a CHK1 Inhibitor, Impairs the Development of Colitis and Colitis-Associated Cancer by Inhibiting CCR2(+) Macrophage Infiltration in Mice
title_fullStr GDC-0575, a CHK1 Inhibitor, Impairs the Development of Colitis and Colitis-Associated Cancer by Inhibiting CCR2(+) Macrophage Infiltration in Mice
title_full_unstemmed GDC-0575, a CHK1 Inhibitor, Impairs the Development of Colitis and Colitis-Associated Cancer by Inhibiting CCR2(+) Macrophage Infiltration in Mice
title_short GDC-0575, a CHK1 Inhibitor, Impairs the Development of Colitis and Colitis-Associated Cancer by Inhibiting CCR2(+) Macrophage Infiltration in Mice
title_sort gdc-0575, a chk1 inhibitor, impairs the development of colitis and colitis-associated cancer by inhibiting ccr2(+) macrophage infiltration in mice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058335/
https://www.ncbi.nlm.nih.gov/pubmed/33897258
http://dx.doi.org/10.2147/OTT.S297132
work_keys_str_mv AT limin gdc0575achk1inhibitorimpairsthedevelopmentofcolitisandcolitisassociatedcancerbyinhibitingccr2macrophageinfiltrationinmice
AT huangtianqing gdc0575achk1inhibitorimpairsthedevelopmentofcolitisandcolitisassociatedcancerbyinhibitingccr2macrophageinfiltrationinmice
AT lixiaolan gdc0575achk1inhibitorimpairsthedevelopmentofcolitisandcolitisassociatedcancerbyinhibitingccr2macrophageinfiltrationinmice
AT shizhiwei gdc0575achk1inhibitorimpairsthedevelopmentofcolitisandcolitisassociatedcancerbyinhibitingccr2macrophageinfiltrationinmice
AT shengyue gdc0575achk1inhibitorimpairsthedevelopmentofcolitisandcolitisassociatedcancerbyinhibitingccr2macrophageinfiltrationinmice
AT humimi gdc0575achk1inhibitorimpairsthedevelopmentofcolitisandcolitisassociatedcancerbyinhibitingccr2macrophageinfiltrationinmice
AT songkui gdc0575achk1inhibitorimpairsthedevelopmentofcolitisandcolitisassociatedcancerbyinhibitingccr2macrophageinfiltrationinmice